Fluorescent visualization and evaluation of NPC1L1- mediated vesicular endocytosis during intestinal cholesterol absorption in mice

Xiaojing Wu, Xian-Hua Ma, Jie Lin, Xiaohang Yang, Jian-Hui Shi, Zhifang Xie, Yu-Xia Chen, Weiping J. Zhang

PDF(1817 KB)
PDF(1817 KB)
Life Metabolism ›› 2023, Vol. 2 ›› Issue (2) : 81-89. DOI: 10.1093/lifemeta/load011
Original Article

Fluorescent visualization and evaluation of NPC1L1- mediated vesicular endocytosis during intestinal cholesterol absorption in mice

Author information +
History +

Abstract

Excessive cholesterol absorption from intestinal lumen contributes to the pathogenesis of hypercholesterolemia, which is an independent risk factor for atherosclerotic cardiovascular disease. Niemann-Pick C1-like 1 (NPC1L1) is a major membrane protein responsible for cholesterol absorption, in which the physiological role of vesicular endocytosis is still controversial, and it lacks a feasible tool to visualize and evaluate the endocytosis of NPC1L1 vesicles in vivo. Here, we genetically labeled endogenous NPC1L1 protein with EGFP in a knock-in mouse model, and demonstrated fluorescent visualization and evaluation of the endocytic vesicles of NPC1L1-cago during intestinal cholesterol absorption. The homozygous NPC1L1-EGFP mice have normal NPC1L1 expression pattern as well as cholesterol homeostasis on chow or high-cholesterol diets. The fluorescence of NPC1L1-EGFP fusion protein localizes at the brush border membrane of small intestine, and EGFP-positive vesicles is visualized beneath the membrane as early as 5 min post oral gavage of cholesterol. Of note, the vesicles colocalize with the early endosomal marker early endosome antigen 1 (EEA1) and the filipin-stained free cholesterol. Pretreatment with NPC1L1 inhibitor ezetimibe inhibits the formation of these cholesterol-induced endocytic vesicles. Our data support the notion that NPC1L1-mediated cholesterol absorption is a vesicular endocytic process. NPC1L1-EGFP mice are a useful model for visualizing cellular NPC1L1-cargo vesicle itineraries and for evaluating NPC1L1 activity in vivo in response to diverse pharmacological agents and nutrients.

Keywords

cholesterol homeostasis / NPC1L1-EGFP / cholesterol transportation / vesicle endocytosis / CRISPR/Cas9 / knock-in mice

Cite this article

Download citation ▾
Xiaojing Wu, Xian-Hua Ma, Jie Lin, Xiaohang Yang, Jian-Hui Shi, Zhifang Xie, Yu-Xia Chen, Weiping J. Zhang. Fluorescent visualization and evaluation of NPC1L1- mediated vesicular endocytosis during intestinal cholesterol absorption in mice. Life Metabolism, 2023, 2(2): 81‒89 https://doi.org/10.1093/lifemeta/load011

References

[1]
Luo J , Yang H , Song BL . Mechanisms and regulation of cholesterol homeostasis. Nat Rev Mol Cell Biol 2020; 21: 225- 45.
[2]
Benjamin EJ , Muntner P , Alonso A et al. American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation 2019; 139: e56- e528.
[3]
Soppert J , Lehrke M , Marx N et al. Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting. Adv Drug Deliv Rev 2020; 159: 4- 33.
[4]
Ference BA , Ginsberg HN , Graham I et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J 2017; 38: 2459- 72.
[5]
Altmann SW , Davis HR Jr , Zhu LJ et al. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science 2004; 303: 1201- 4.
[6]
Davies JP , Scott C , Oishi K et al. Inactivation of NPC1L1 causes multiple lipid transport defects and protects against diet-induced hypercholesterolemia. J Biol Chem 2005; 280: 12710- 20.
[7]
Davies JP , Levy B , Ioannou YA . Evidence for a Niemann-pick C (NPC) gene family: identification and characterization of NPC1L1. Genomics 2000; 65: 137- 45.
[8]
Wang J , Chu BB , Ge L et al. Membrane topology of human NPC1L1, a key protein in enterohepatic cholesterol absorption. J Lipid Res 2009; 50: 1653- 62.
[9]
Zhang JH , Ge L , Qi W et al. The N-terminal domain of NPC1L1 protein binds cholesterol and plays essential roles in cholesterol uptake. J Biol Chem 2011; 286: 25088- 97.
[10]
Li PS , Fu ZY , Zhang YY et al. The clathrin adaptor Numb regulates intestinal cholesterol absorption through dynamic interaction with NPC1L1. Nat Med 2014; 20: 80- 6.
[11]
Xie 谢畅 C , Zhou 周章森 ZS , Li 李钠 N et al. Ezetimibe blocks the internalization of NPC1L1 and cholesterol in mouse small intestine. J Lipid Res 2012; 53: 2092- 101.
[12]
Temel RE , Tang W , Ma Y et al. Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe. J Clin Invest 2007; 117: 1968- 78.
[13]
Alrefai WA , Annaba F , Sarwar Z et al. Modulation of human Niemann-Pick C1-like 1 gene expression by sterol: role of sterol regulatory element binding protein 2. Am J Physiol Gastrointest Liver Physiol 2007; 292: G369- 76.
[14]
Pramfalk C , Jiang ZY , Cai Q et al. HNF1alpha and SREBP2 are important regulators of NPC1L1 in human liver. J Lipid Res 2010; 51: 1354- 62.
[15]
Yu L , Bharadwaj S , Brown JM et al. Cholesterol-regulated translocation of NPC1L1 to the cell surface facilitates free cholesterol uptake. J Biol Chem 2006; 281: 6616- 24.
[16]
Jia L , Betters JL , Yu L . Niemann-pick C1-like 1 (NPC1L1) protein in intestinal and hepatic cholesterol transport. Annu Rev Physiol 2011; 73: 239- 59.
[17]
Ge L , Wang J , Qi W et al. The cholesterol absorption inhibitor ezetimibe acts by blocking the sterol-induced internalization of NPC1L1. Cell Metab 2008; 7: 508- 19.
[18]
Zhang YY , Fu ZY , Wei J et al. A LIMA1 variant promotes low plasma LDL cholesterol and decreases intestinal cholesterol absorption. Science 2018; 360: 1087- 92.
[19]
Xie C , Li N , Chen ZJ et al. The small GTPase Cdc42 interacts with Niemann-Pick C1-like 1 (NPC1L1) and controls its movement from endocytic recycling compartment to plasma membrane in a cholesterol-dependent manner. J Biol Chem 2011; 286: 35933- 42.
[20]
Ge L , Qi W , Wang LJ et al. Flotillins play an essential role in Niemann-Pick C1-like 1-mediated cholesterol uptake. Proc Natl Acad Sci U S A 2011; 108: 551- 6.
[21]
Garcia-Calvo M , Lisnock J , Bull HG et al. The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1). Proc Natl Acad Sci U S A 2005; 102: 8132- 7.
[22]
Weinglass AB , Kohler M , Schulte U et al. Extracellular loop C of NPC1L1 is important for binding to ezetimibe. Proc Natl Acad Sci U S A 2008; 105: 11140- 5.
[23]
Johnson TA , Pfeffer SR . Ezetimibe-sensitive cholesterol uptake by NPC1L1 protein does not require endocytosis. Mol Biol Cell 2016; 27: 1845- 52.
[24]
Liu G , Zhou L , Zhang H et al. Regulation of hepatic lipogenesis by the zinc finger protein Zbtb20. Nat Commun 2017; 8: 14824.
[25]
Petersen NH , Færgeman NJ , Yu L et al. Kinetic imaging of NPC1L1 and sterol trafficking between plasma membrane and recycling endosomes in hepatoma cells. J Lipid Res 2008; 49: 2023- 37.
[26]
Xie P , Zhu H , Jia L et al. Genetic demonstration of intestinal NPC1L1 as a major determinant of hepatic cholesterol and blood atherogenic lipoprotein levels. Atherosclerosis 2014; 237: 609- 17.

RIGHTS & PERMISSIONS

2023 The Author(s) 2023. Published by Oxford University Press on behalf of Higher Education Press.
AI Summary AI Mindmap
PDF(1817 KB)

Accesses

Citations

Detail

Sections
Recommended

/